Smešný Trtková Kateřina Ph.D.

Smešný Trtková Kateřina Ph.D.'s picture

Publications (Impact Factor Journals):

  • [5]
    FIALOVÁ, B., P. LUŽNÁ, J. GURSKÝ, K. LANGOVÁ, Z. KOLÁŘ a K. SMEŠNÝ TRTKOVÁ. Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine. Oncology Reports. 2016, 36, 2365-2374. ISSN 1021-335X . IF: 2.662. PMID: 27499010
  • [4]
    REPTOVA, S., K. SMEŠNÝ TRTKOVÁ a Z. KOLÁŘ. Direct Detection of the AR-E211 G > A Gene Polymorphism from Blood and Tissue Samples Without DNA Isolation. Pathology & Oncology Research. 2014, 20(2), 223-227. ISSN 1219-4956. IF: 1.855. PMID: 24634161
  • [3]
    PASKOVA, L., K. SMEŠNÝ TRTKOVÁ, B. FIALOVÁ, A. BENEDÍKOVÁ, K. LANGOVÁ a Z. KOLÁŘ. Different effect of sodium butyrate on cancer and normal prostate cells. Toxicology in Vitro. 2013, 27(5), 1489-1495. ISSN 0887-2333. IF: 3.207. PMID: 23524101
  • [2]
    FIALOVÁ, B., K. SMEŠNÝ TRTKOVÁ, L. PASKOVA, K. LANGOVÁ a Z. KOLÁŘ. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines. Oncology Reports. 2013, 29(5), 2039-2045. ISSN 1021-335X. IF: 2.191. PMID: 23503510
  • [1]
    KHARAISHVILI, G., D. ŠIMKOVÁ, E. MAKHAROBLIDZE, K. TRKOVÁ, Z. KOLÁŘ a J. BOUCHAL. WNT signaling in prostate development and carcinogenesis. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2011, 1(55), 11-18. ISSN 1213-8118. IF: 0.702. PMID: 21475372

Book Chapters:

  • [1]
    SMEŠNÝ TRTKOVÁ, K. Androgen Receptor as a Traget for Epigenetic Therapy of Castration Resistant Prostate Cancer (CRPC) . In: Recent Advances in Prostate Cancer. -. -: Avid Science, 2017. Kapitola 5, s. xx. ISBN: 978-93-86337-47-4.

Doctoral students mentor:

[6] Denisa Hrčková-Drozdová, Effect of histone deacetylase inhibitors on apoptosis and proliferative activity of cancer cells,
Ph.D. specialization: Medical biology, status: Ongoing, from: 2016
[5] Martina Paprskářová, Role of p53 in tumor prostate cells affected by histone deacetylases,
Ph.D. specialization: , status: Interrupted, from: 2014 to 2015
[4] Petra Lužná, Methylation status in patients with multiple myeloma,
Ph.D. specialization: , status: Ongoing, from: 2014
[3] Pavla Flodrová, The study and the possibility of regulation of the molecular mechanisms in haematological malignancies,
Ph.D. specialization: , status: Interrupted, from: 2011
[2] Lenka Kocourková, Effect of coregulators on the androgen receptor activity in cells derived from prostate cancer after their treatment with histone deacetylase inhibitor,
Ph.D. specialization: , status: Ongoing, from: 2009
[1] Barbora Fialová, Implications of epigenetic changes in cells derived from prostate cancer,
Ph.D. specialization: , status: Interrupted, from: 2009


Master students mentor:

[3] Veronika Frýbortová, Quantification of methylation changes of TET protein and their effect on total methylation of DNA and hydroxymethylation in a patient with multiple myeloma,
status: Ongoing, from: 2018
[2] Eva Gottwaldová, Comparison of the expression profile of the selected tumor suppressor genes with the methylation level in the promoter of these genes,
status: Ongoing, from: 2018
[1] Kateřina Sikorová, Quantification of methylation by pyrosequencing in hemato-onkological diseases,
status: Graduated, from: 2015